Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 4.67 Delayed Data As of Dec 06 |  -0.04 / -0.85%Today’s Change | 1.85 Today|||52-Week Range 7.67 | +143.23% Year-to-Date |
Latest CPRX News | Press Releases
No recent news for Catalyst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.71 |
| Today’s open | 4.78 |
| Day’s range | 4.61 - 4.87 |
| Volume | 2,334,887 |
| Average volume (3 months) | 2,315,060 |
| Market cap | $480.2M |
Data as of 4:15pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | -57.76% |
| Earnings growth (this year) | +200.61% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 51.9 |
| Price/Sales | 394.11 |
| Price/Book | 9.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MGNXMacroGenics Inc | +0.42 | +4.59% |
| CRNXCrinetics Pharmaceut... | +0.33 | +1.65% |
| IPHAInnate Pharma SA | -0.07 | -1.12% |
| STMLStemline Therapeutic... | +0.50 | +5.15% |
Data as of 4:00pm ET, 12/06/2019
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | $0.10 |
| Annual revenue (last year) | $500.0K |
| Annual profit (last year) | -$34.0M |
| Net profit margin | -6,800.70% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Coral Gables, Florida |
Forecasts
